Formulary Search
Search Results : Chronic Kidney Disease (Sucroferric oxyhydroxide - Chronic Kidney Disease)
Show Icon and Status Keys
Hyperphosphataemia in patients with chronic kidney disease
Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.
- Tablets
If a patient with diabetes were on insulin and on multiple other treatments, a discussion with the specialist team may be prudent prior to dapagliflozin initiation.
- Tablets
Dapagliflozin is the preferred SGLT-2 for CKD.
If a patient with diabetes were on insulin and on multiple other treatments, a discussion with the specialist team may be prudent prior to Empagliflozin initiation.
- Tablets
Hyperphosphataemia in patients with chronic renal failure
Hyperphosphataemia in patients with chronic renal failure - On recommendation from a specialist renal centre, locally those centres are Epsom & St Helier, Frimley or Brighton.
- Injection
Pruritus (associated with chronic kidney disease in patients on haemodialysis)
Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.
- Injection
Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis
Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.
- Tablets
Stage 3 and 4, associated with Type 2 diabetes as per NICE TA877
Hyperphosphataemia in patients with chronic kidney disease
Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.
- Oral suspension
- Tablets
Symptomatic anaemia associated with chronic kidney disease
Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.